Pharmaceutical

TheracosBio and BAMCO to bring BRENZAVVY to sub-Saharan...

TheracosBio has entered a partnership with BAMCO Africa to deliver BRENZAVVY (be...

Unresolved clawback issues obstruct Greece’s potential ...

A potential three-year framework agreement between the Greek government and the ...

Sanofi and Orano Med link for radioligand therapy devel...

Sanofi and Orano Group subsidiary Orano Med have announced a partnership to enha...

Opioid addiction market to reach $2.4 billion across 8M...

Late-stage pipeline products could drive combined sales of approximately $171.4 ...

US Elections: how healthcare could look under a Harris ...

With less than three weeks until Americans cast their vote, what would healthcar...

FDA approves AbbVie’s VYALEV for advanced Parkinson’s t...

The US FDA has approved AbbVie's VYALEV to treat motor fluctuations in adults wi...

Intercept’s liver disease drug Ocaliva faces FDA approv...

An FDA AdCom in September recommended against full approval for Ocaliva by a 13-...

MSD mulls 2025/26 launch for RSV vaccine after Phase II...

A Phase IIb/III trial with infants entering their first respiratory syncytial vi...

Avadel wins FDA approval for narcolepsy drug Lumryz in ...

The expanded approval intensifies the rivalry with Jazz Pharmaceuticals, which h...

mRNA licensing agreements surge 800% amid GSK lawsuits

An 800% increase in licensing deal values indicates growing confidence in mRNA t...

Radiopharm and AtomVie partner on radioantibody develop...

Radiopharm Theranostics (RAD) and AtomVie have announced a partnership for the d...

Sage lays off 55% of R&D workforce and refocuses pipeline

Strategic restructuring will support the ongoing launch of the oral postpartum d...

Bavarian Nordic’s mpox vaccine equally effective in tee...

Bavarian Nordic’s MVA-BN vaccine showed equivalent antibody response and safety ...

Fresenius Kabi and Cellular Origins agree CGT manufactu...

Fresenius Kabi and Cellular Origins have announced a partnership to advance cell...

Glaukos eyes FDA approval for ocular therapy after Phas...

The company’s keratoconus medication, Epioxa, was effective in a Phase III trial...

Health Canada approves Acadia’s DAYBUE for Rett syndrome

Acadia Pharmaceuticals has received marketing authorisation from Health Canada f...